The exact risk remains uncertain
Common symptoms Fewer than three bowel movements per week Hard, dry, or lumpy stools Straining during bowel movements Sensation of incomplete emptying of bowels Abdominal discomfort, bloating, or cramping Feeling of fullness or pressure in the rectum Possible nausea or reduced appetite How common is constipation with GLP-1 treatments
Compounded Semaglutide: How Do They Stack Up against Each Other
Concordantly, mice deficient in Aldh2 and Adh5 recapitulate some of the hematopoietic phenotypes of IBMFS/AMeD patients 10
Limited published studies exist on this specific combination
If markers have not changed, discuss with your provider whether to: Increase the dose modestly (0.25 to 0.5 mg increment) Add a split-dosing approach for steadier levels Focus on optimizing complementary factors before further dose changes Consider whether standard dosing might be more appropriate for your situation Step 5: Long-term monitoring and adjustment If the protocol is working, continue with quarterly blood work and ongoing symptom tracking